Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Sequential Cohort, Open-Label, Dose-escalation Study of the Safety and CNS Pharmacokinetics of Dexanabinol in Patients With Brain Cancer

NCT01654497 is registered in ClinicalTrials.gov with Santosh Kesari, M.D., Ph.D. as lead sponsor.

NCT NCT01654497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01654497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Sequential Cohort, Open-Label, Dose-escalation Study of the Safety and CNS Pharmacokinetics of Dexanabinol in Patients With Brain Cancer
Lead sponsor
Santosh Kesari, M.D., Ph.D.
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2012
Completion date
July 31, 2017
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer